| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Neurology (Drs. Parsons, Darby, Gerraty, Davis, and Barber) and Radiology (Drs. Li, Yang, and Tress, P.M. Desmond), the Royal Melbourne Hospital, Victoria, Australia.
Address correspondence and reprint requests to Dr. Stephen Davis, Director of Neurology, the Royal Melbourne Hospital, Parkville, Victoria, Australia 3050; e-mail: sdavis{at}ariel.its.unimelb.edu.au
BACKGROUND: The prognostic value of the biochemical changes seen with proton MR spectroscopy (1H MRS) in ischemic stroke was examined. Acute diffusion-weighted imaging (DWI) was used to identify regions of ischemia for 1H MRS voxel localization.
METHODS: Nineteen patients had 36 1H MRS studies, 13 patients acutely (mean, 11.1 hours), 10 subacutely (mean, 3.9 days), and 13 at outcome (mean, 82 days). Single-voxel, long-echo, timepoint-resolved spectroscopy was used to obtain lactate, N-acetylaspartate (NAA), choline, and creatine levels from the infarct core. Outcome measures were final infarct volume and clinical assessment scales (Canadian Neurological Scale, Barthel Index, and Rankin Scale).
RESULTS: Acute lactate/choline ratio correlated more strongly with clinical outcome scores (r = 0.76 to 0.83; p < 0.01) and final infarct size (r = 0.96; p < 0.01) than acute DWI lesion volume or acute NAA/choline ratio. Combination of acute lactate/choline ratio with acute DWI lesion volume improved prediction of all outcome scores (R2 = 0.80 to 0.90). The predictive effect of acute lactate/choline ratio was independent of acute DWI lesion volume (p < 0.001). In subacute and chronic infarction, both lactate/choline and NAA/choline ratios continued to correlate with outcome (p < 0.05). At the chronic stage, persistent lactate/choline ratio elevation strongly correlated with outcome measures (r = 0.71 to 0.87).
CONCLUSION: Lactate/choline ratio measured in the acute infarct core by 1H MRS improves the prediction of stroke outcome and provides prognostic information complementary to DWI. Lactate/choline ratio could be used as an additional marker to select patients for acute and chronic therapies.
This article has been cited by other articles:
|
|
 |
|
  S. Munoz Maniega, V. Cvoro, P. A. Armitage, I. Marshall, M. E. Bastin, and J. M. Wardlaw Choline and Creatine Are Not Reliable Denominators for Calculating Metabolite Ratios in Acute Ischemic Stroke Stroke, September 1, 2008; 39(9): 2467 - 2469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. E. Benarroch N-Acetylaspartate and N-acetylaspartylglutamate: Neurobiology and clinical significance Neurology, April 15, 2008; 70(16): 1353 - 1357. [Full Text] [PDF]
|
|
|
|
|
|
T. Bartsch, K. Alfke, S. Wolff, A. Rohr, O. Jansen, and G. Deuschl Focal MR spectroscopy of hippocampal CA-1 lesions in transient global amnesia Neurology, March 25, 2008; 70(13): 1030 - 1035. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-R. Zhao, H. H. Berra, W.-M. Duan, S. Singhal, J. Mehta, A. V. Apkarian, and J. A. Kessler Beneficial Effects of Hematopoietic Growth Factor Therapy in Chronic Ischemic Stroke in Rats Stroke, October 1, 2007; 38(10): 2804 - 2811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Singhal, E. Ratai, T. Benner, M. Vangel, V. Lee, W. J. Koroshetz, P. W. Schaefer, A. G. Sorensen, and R. G. Gonzalez Magnetic Resonance Spectroscopy Study of Oxygen Therapy in Ischemic Stroke Stroke, October 1, 2007; 38(10): 2851 - 2854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Banks and C. A. Marotta Outcomes Validity and Reliability of the Modified Rankin Scale: Implications for Stroke Clinical Trials: A Literature Review and Synthesis Stroke, March 1, 2007; 38(3): 1091 - 1096. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Schiemanck, G. Kwakkel, M. W. M. Post, and A. J. H. Prevo Predictive Value of Ischemic Lesion Volume Assessed With Magnetic Resonance Imaging for Neurological Deficits and Functional Outcome Poststroke: A Critical Review of the Literature. Neurorehabil Neural Repair, December 1, 2006; 20(4): 492 - 502. [Abstract] [PDF]
|
|
|
|
 |
|
 A.L. Coon, F. Arias-Mendoza, G.P. Colby, J. Cruz-Lobo, J. Mocco, W.J. Mack, R.J. Komotar, T.R. Brown, and E.S. Connolly Jr. Correlation of Cerebral Metabolites with Functional Outcome in Experimental Primate Stroke Using in Vivo 1H-Magnetic Resonance Spectroscopy. AJNR Am. J. Neuroradiol., May 1, 2006; 27(5): 1053 - 1058. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Mitsias, J. R. Ewing, M. Lu, M. M. Khalighi, M. Pasnoor, H. B. Ebadian, Q. Zhao, S. Santhakumar, M. A. Jacobs, N. Papamitsakis, et al. Multiparametric Iterative Self-Organizing MR Imaging Data Analysis Technique for Assessment of Tissue Viability in Acute Cerebral Ischemia AJNR Am. J. Neuroradiol., October 1, 2004; 25(9): 1499 - 1508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Clement, S. S. Braithwaite, M. F. Magee, A. Ahmann, E. P. Smith, R. G. Schafer, and I. B. Hirsch Management of Diabetes and Hyperglycemia in Hospitals Diabetes Care, February 1, 2004; 27(2): 553 - 591. [Full Text] [PDF]
|
|
|
|
|
|
C. S. Kidwell, J. R. Alger, and J. L. Saver Beyond Mismatch: Evolving Paradigms in Imaging the Ischemic Penumbra With Multimodal Magnetic Resonance Imaging Stroke, November 1, 2003; 34(11): 2729 - 2735. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Nicoli, Y. Lefur, B. Denis, J.P. Ranjeva, S. Confort-Gouny, and P.J. Cozzone Metabolic Counterpart of Decreased Apparent Diffusion Coefficient During Hyperacute Ischemic Stroke: A Brain Proton Magnetic Resonance Spectroscopic Imaging Study Stroke, July 1, 2003; 34 (7): e82 - e87. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. P. Adams Jr, R. J. Adams, T. Brott, G. J. del Zoppo, A. Furlan, L. B. Goldstein, R. L. Grubb, R. Higashida, C. Kidwell, T. G. Kwiatkowski, et al. Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association Stroke, April 1, 2003; 34(4): 1056 - 1083. [Full Text] [PDF]
|
|
|
|
 |
|
 M. K. Zarifi, L. G. Astrakas, T. Y. Poussaint, A. d. Plessis, D. Zurakowski, and A. A. Tzika Prediction of Adverse Outcome with Cerebral Lactate Level and Apparent Diffusion Coefficient in Infants with Perinatal Asphyxia Radiology, December 1, 2002; 225(3): 859 - 870. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Flemming, S. Ulmer, B. Duisberg, A. Hahn, and O. Jansen MR Spectroscopic Findings in a Case of Alpers-Huttenlocher Syndrome AJNR Am. J. Neuroradiol., September 1, 2002; 23(8): 1421 - 1423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Graham, J.-H. Hwang, D. L. Rothman, and J. W. Prichard Spectroscopic Assessment of Alterations in Macromolecule and Small-Molecule Metabolites in Human Brain After Stroke Stroke, December 1, 2001; 32(12): 2797 - 2802. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kobayashi, H. Takayama, S. Suga, B. Mihara, G. A. Rosenberg, and W. M. Brooks Longitudinal Changes of Metabolites in Frontal Lobes After Hemorrhagic Stroke of Basal Ganglia: A Proton Magnetic Resonance Spectroscopy Study Editorial Comment: A Proton Magnetic Resonance Spectroscopy Study Stroke, October 1, 2001; 32(10): 2237 - 2245. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
